IBM’s 42% Mainframe Collapse: When AI’s Appetite Devours the Cash Cow
Published on 07/24/2026 at 05:53 | Redaktion boerse-global.de
The arithmetic is brutal but simple: every dollar a corporate customer spends on AI servers and memory chips is a dollar not spent on IBM’s mainframes. That equation produced a second-quarter reckoning that sent Big Blue’s stock to within a hair of its 52-week low, erased $67 billion in market value in a single day, and forced management to slash its revenue forecast for the year.
IBM reported earnings on July 23, 2026, delivering revenue of $17.16 billion — a modest 1.1% increase year-over-year but well below the consensus range of up to $17.86 billion. Adjusted earnings per share of $2.93 also missed expectations of $2.97. The damage, however, had largely been priced in after a pre-announcement on July 14 triggered a roughly 25% single-day plunge — the worst trading session for the stock since the Black Monday crash of 1987.
The Mainframe Freefall
The culprit is unambiguous. Infrastructure revenue fell 7.4% to $3.84 billion, while mainframe sales cratered by 42%. Just one quarter earlier, that same business had been posting robust gains — a whiplash-inducing reversal that underscores how quickly CFOs are reallocating budgets toward AI infrastructure.
CEO Arvind Krishna insists the weakness is a timing issue, not a structural one. “It’s a shift, not a destruction,” he told analysts, pointing to a third of the delayed large contracts that were closed within three weeks of the quarter’s end. Finance chief Kavanaugh reinforced the argument with a multiplier: every dollar of mainframe hardware typically generates three dollars in software revenue, making the platform’s long-term economics too compelling to abandon.
Should investors sell immediately? Or is it worth buying IBM?
The company now expects constant-currency revenue growth of 4% to 5% for the full year, down from the prior target of over 5%. Kavanaugh initially described the lower end of that range as an “anchor” before later calling it the “base case” — a semantic shift that left some analysts scratching their heads. IBM did, however, reaffirm its commitment to boosting free cash flow by roughly $1 billion year-over-year.
Software Holds the Line
Amid the hardware carnage, the software segment offered a counter-narrative. Revenue climbed 5.1% to $7.76 billion, powered by Red Hat’s 11% growth and a 19% jump in the data business. The annualized recurring revenue base expanded 8% to $24.6 billion, reflecting the subscription-model shift that now underpins most of the division’s sales.
The consulting arm, by contrast, was essentially flat at $5.33 billion — a reminder that the services engine isn’t picking up the slack either.
A Stock at the Breaking Point
The shares traded at €179.02 on the day of the earnings release, down 0.53%, putting them just 2.17% above the 52-week low of €175.22 hit that same day. The primary article records a slightly different low of €175.14 on July 23, with the stock at €181.74, but both paint the same picture: a stock hovering near its floor. The relative strength index has sunk to 29.5, signaling oversold territory, while 30-day annualized volatility has spiked to 84% — a measure of just how unsettled the market is about the reduced guidance.
From the 52-week high of €292.85 reached on June 1, 2026, the stock has shed nearly 38%. Year-to-date, the decline stands at roughly 30%.
Analysts Split on What Comes Next
The divergence among Wall Street firms reflects the central question: is this a temporary pause or a permanent shift? Barclays sees a bull-case target of $288, while Wedbush goes as high as $350. Jefferies held its $260 target, attributing the software slowdown to pure timing effects. Stifel is more cautious at $235, and the bear-case scenario lands at $175 — essentially where the stock is trading now.
IBM at a turning point? This analysis reveals what investors need to know now.
Betting on the Next Frontier
IBM isn’t waiting for the mainframe cycle to recover. On July 23, the same day it reported earnings, the company signed a binding agreement to acquire HRL Laboratories, a move aimed at advancing silicon spin-qubit technology for quantum computing. The deal is expected to close by the end of the third quarter, adding another piece to a multiyear, multibillion-dollar quantum bet.
The gap between the current share price and the analyst consensus of €238.58 is 31.3% — a spread that looks either like a bargain or a value trap, depending on whether Krishna’s “deferred, not destroyed” thesis holds. The company’s free cash flow targets, which call for year-over-year improvement, suggest the operating engine is still generating ample capital despite the turmoil.
The next quarterly report will be the real test. If the delayed June contracts return in full, the narrative shifts back to IBM’s favor. If they don’t, the question becomes whether software growth and quantum dreams can ever compensate for a mainframe business that just lost 42% of its revenue in three months.
Ad
IBM Stock: New Analysis - 24 July
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
